Advertisement

Research Article Free access | 10.1172/JCI113391

Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.

S D Revak, T A Merritt, E Degryse, L Stefani, M Courtney, M Hallman, and C G Cochrane

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

Find articles by Revak, S. in: JCI | PubMed | Google Scholar

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

Find articles by Merritt, T. in: JCI | PubMed | Google Scholar

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

Find articles by Degryse, E. in: JCI | PubMed | Google Scholar

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

Find articles by Stefani, L. in: JCI | PubMed | Google Scholar

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

Find articles by Courtney, M. in: JCI | PubMed | Google Scholar

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

Find articles by Hallman, M. in: JCI | PubMed | Google Scholar

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

Find articles by Cochrane, C. in: JCI | PubMed | Google Scholar

Published March 1, 1988 - More info

Published in Volume 81, Issue 3 on March 1, 1988
J Clin Invest. 1988;81(3):826–833. https://doi.org/10.1172/JCI113391.
© 1988 The American Society for Clinical Investigation
Published March 1, 1988 - Version history
View PDF
Abstract

Two low molecular weight (LMW) apoproteins were isolated from human pulmonary surfactant. SDS polyacrylamide gel analysis showed one protein (SP 18) to have an apparent molecular weight of 18,000 when unreduced and 9,000 D after reduction. The second protein (SP 9) migrated at approximately 9,000 D in the presence or absence of reducing agents. Both proteins contain a high number of hydrophobic amino acids. The NH2-terminal sequence of SP 18 was determined to be: NH2-phe-pro-ile-pro-leu-pro-tyr-. A cDNA clone isolated from a human adult lung cDNA library contained a long open reading frame encoding at an internal position the human SP 18 amino-terminal sequence. Mixtures of phospholipids (PL) and SP 9 and SP 18 were assessed for their capacity to reduce surface tensions on a pulsating bubble surfactometer. The addition of 1% apoprotein resulted in a reduction of surface tension after 15 s from 42.9 dyn/cm for PL alone to 16.7 and 6.3 dyn/cm for preparations containing SP 9 and SP 18, respectively. In vivo assessment of reconstituted surfactant activity was performed in fetal rabbits. Reconstituted surfactant consisting of PL + 0.5% SP 18 instilled intratracheally at delivery resulted in a marked increase in lung compliance, while the incorporation of 0.5% SP 9 yielded a moderate increase. These data show the ability to produce biologically active surfactant by the addition of isolated LMW apoproteins to defined PL.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (March 1, 1988): No description
Advertisement
Advertisement